SOPHiA GENETICS (SOPH) Income from Continuing Operations (2020 - 2025)

SOPHiA GENETICS (SOPH) has 6 years of Income from Continuing Operations data on file, last reported at 19969000.0 in Q4 2025.

• For the quarter ending Q4 2025, Income from Continuing Operations fell 43.39% year-over-year to 19969000.0; the trailing twelve-month figure through Dec 2025 stood at 75975000.0 (down 26.53% YoY), and the FY2025 full-year result was 75975000.0, down 26.53% from the prior year.
• Income from Continuing Operations fell to 19969000.0 in Q4 2025, from 18737000.0 in the prior quarter.
• In the past five years, Income from Continuing Operations ranged from a high of 12318000.0 in Q1 2021 to a low of 25021000.0 in Q1 2022.
• A 5-year average of 18755100.0 and a median of 19111500.0 in 2023 frame the typical range for Income from Continuing Operations.
• Across the five-year window, Income from Continuing Operations jumped 99.81% in 2021 and plunged 103.13% in 2022, its largest moves.
• Tracing SOPH's Income from Continuing Operations over 5 years: stood at 22424000.0 in 2021, then soared by 35.4% to 14485000.0 in 2022, then sank by 66.1% to 24060000.0 in 2023, then soared by 42.12% to 13926000.0 in 2024, then sank by 43.39% to 19969000.0 in 2025.
• Business Quant data shows SOPH's Income from Continuing Operations at 19969000.0 in Q4 2025, 18737000.0 in Q3 2025, and 20890000.0 in Q2 2025.